ResearcherInsermNo recent work listed
Amélie Anota
Matched on ORCID iD 0000-0001-6896-1367; OpenAlex author ID A5012447228. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial. Co-author DOI 10.6004/jnccn.2023.7065↗
- Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leu… Co-author DOI 10.1002/cam4.2311↗
- Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A… Co-author DOI 10.1371/journal.pone.0125350↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christophe Tournigand · 2 shared papers, 2019–2023 · strength 0.22
- Paper Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial. DOI 10.6004/jnccn.2023.7065↗
- Paper Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel p… DOI 10.1002/cam4.2311↗
- Pascal R. Hammel · 2 shared papers, 2019–2023 · strength 0.22
- Paper Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial. DOI 10.6004/jnccn.2023.7065↗
- Paper Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel p… DOI 10.1002/cam4.2311↗
- Cindy Neuzillet · 1 shared paper, 2023 · strength 0.14
- Thierry Conroy · 1 shared paper, 2023 · strength 0.14
- Astrid Lièvre · 1 shared paper, 2023 · strength 0.14
- Olivier Bouché · 1 shared paper, 2023 · strength 0.14
- Franck Bonnetain · 2 shared papers, 2015–2019 · strength 0.12
- Paper Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel p… DOI 10.1002/cam4.2311↗
- Paper Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with… DOI 10.1371/journal.pone.0125350↗
- Julien Taı̈eb · 2 shared papers, 2015–2019 · strength 0.12
- Paper Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel p… DOI 10.1002/cam4.2311↗
- Paper Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with… DOI 10.1371/journal.pone.0125350↗
- Romain Cohen · 1 shared paper, 2019 · strength 0.08
- Émilie Charton · 1 shared paper, 2019 · strength 0.08
- P. Debourdeau · 1 shared paper, 2019 · strength 0.08
- Christophe Louvet · 1 shared paper, 2019 · strength 0.08
- Jean‐Baptiste Bachet · 1 shared paper, 2019 · strength 0.08
- Aziz Zaanan · 1 shared paper, 2015 · strength 0.04
- Isabelle Trouilloud · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.